PPARα ligands inhibitthe growth of colon, breast, endometrial, and skin cells in vitro [46, 48, 50–52] and humanovarian cancer [53],melanoma, lung carcinoma, glioblastoma, and fibrosarcoma [48]. Here, PPARA is linked to melanoma.